Back to search

Article

Modelling the role of dual specificity phosphatases in Herceptin resistant breast cancer cell lines

2019-01-23

Abstract excerpt

<h4>Background</h4> Breast cancer remains the most lethal type of cancer for women. A significant proportion of breast cancer cases are characterised by overexpression of the human epidermal growth factor receptor 2 protein (HER2). These cancers are commonly treated by Herceptin (Trastuzumab), but resistance to drug treatment frequently develops in tumour cells. Dual-specificity phosphatases (DUSPs) are thought t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1352913-a9df-5bb5-a202-0f1c3fe01fc8
DOI
10.1101/528315
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modelling the role of dual specificity phosphatases in Herceptin resistant breast cancer cell linesDOI 10.1101/528315
Select a neighboring publication to make it the new centre.